Overview of Trimox (Amoxicillin)
The following quick facts define the identity and core properties of the medication Trimox (Amoxicillin).
| Property | Description |
|---|---|
| Active ingredient | Amoxicillin (C16H19N3O5S) |
| Form | Capsule, Tablet, Oral Suspension |
| Pharmacological class | beta-Lactam Antibiotic, Aminopenicillin |
| Common use | Systemic Anti-infective |
| Origin | Semisynthetic |
What Type of Antibiotic is Trimox (Amoxicillin)?
Trimox is a trade name for the drug Amoxicillin, which is fundamentally a semisynthetic penicillin that serves as a powerful, broad-spectrum systemic anti-infective agent. This medicine belongs to the aminopenicillin group, a key subclass within the larger classification of beta-Lactam antibiotics. Amoxicillin's chemical structure is synthesized from the basic penicillin core, classifying it as derived rather than naturally occurring. This agent's general purpose is to provide a fundamental defense against pathogenic bacteria by actively killing the infectious organisms, a function established by its pharmacological properties.
Amoxicillin is utilized for reducing the burden of susceptible bacterial infections across various parts of the body, indicating its value for systemic bacterial control. The drug is exclusively available as a prescription-only medicine, underscoring its therapeutic potency and the requirement for professional medical supervision. Other popular generic and branded products contain the same Amoxicillin formulation.
Active Ingredient and Common Forms of Amoxicillin
The sole active ingredient in this medication is Amoxicillin, confirming that the product is a single-entity product. Amoxicillin is provided in several pharmaceutical preparations for oral administration. These available dosage form(s) typically include solid formats, such as the capsule and tablet (which may include chewable varieties), and liquid formats, such as the oral suspension or powder for oral suspension. This deliberate formulation diversity ensures flexibility in administration, making the agent suitable for various patient populations, particularly those who may have difficulties swallowing standard pills, while ensuring consistent delivery of the systemic anti-infective component.
Regulatory References
_EN.png)
